Literature DB >> 32416262

Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool.

Nicholas Kovacs1, Katy Benjamin2, Nicole Holland-Thomas3, Olga Moshkovich2, Linda M Nelsen4, Hector Ortega5, Ethan J Schwartz2, Jonathan Steinfeld4, Suyong Yun Kirby6, Amy Klion3, Paneez Khoury7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32416262      PMCID： PMC7554136          DOI： 10.1016/j.jaip.2020.04.069

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  6 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

2.  Heterogeneity among characteristics of hypereosinophilic syndromes.

Authors:  Grzegorz Helbig; Andrzej Moskwa; Marek Hus; Krzysztof Woźniczka; Agata Wieczorkiewicz; Joanna Dziaczkowska-Suszek; Anna Soja; Aleksandra Bartkowska-Chrobok; Sławomira Kyrcz-Krzemień
Journal:  J Allergy Clin Immunol       Date:  2010-04-14       Impact factor: 10.793

Review 3.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

Review 4.  Patient-Reported Outcomes in Systemic Lupus Erythematosus.

Authors:  Mary Mahieu; Susan Yount; Rosalind Ramsey-Goldman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

5.  Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Authors:  Alain M Schoepfer; Alex Straumann; Radoslaw Panczak; Michael Coslovsky; Claudia E Kuehni; Elisabeth Maurer; Nadine A Haas; Yvonne Romero; Ikuo Hirano; Jeffrey A Alexander; Nirmala Gonsalves; Glenn T Furuta; Evan S Dellon; John Leung; Margaret H Collins; Christian Bussmann; Peter Netzer; Sandeep K Gupta; Seema S Aceves; Mirna Chehade; Fouad J Moawad; Felicity T Enders; Kathleen J Yost; Tiffany H Taft; Emily Kern; Marcel Zwahlen; Ekaterina Safroneeva
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

6.  Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.

Authors:  Princess U Ogbogu; Bruce S Bochner; Joseph H Butterfield; Gerald J Gleich; Johannes Huss-Marp; Jean Emmanuel Kahn; Kristin M Leiferman; Thomas B Nutman; Florian Pfab; Johannes Ring; Marc E Rothenberg; Florence Roufosse; Marie-Helene Sajous; Javed Sheikh; Dagmar Simon; Hans-Uwe Simon; Miguel L Stein; Andrew Wardlaw; Peter F Weller; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793
  6 in total
  1 in total

1.  Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome.

Authors:  Fabrizio Pane; Guillaume Lefevre; Namhee Kwon; Jane H Bentley; Steven W Yancey; Jonathan Steinfeld
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.